当前位置:首页 - 行情中心 - 维康药业(300878) - 财务分析 - 现金流量表

维康药业

(300878)

  

流通市值:40.40亿  总市值:40.58亿
流通股本:1.44亿   总股本:1.45亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金116,788,638.4279,123,743.7736,935,987.22220,764,813.04
  收到的税费返还3,318,619.093,233,862.38-2,189,996.78
  收到其他与经营活动有关的现金13,152,514.826,259,916.615,264,900.264,610,585.43
  经营活动现金流入小计133,259,772.3388,617,522.7642,200,887.42287,565,395.25
  购买商品、接受劳务支付的现金41,954,122.4226,816,840.3713,764,07550,226,980.09
  支付给职工以及为职工支付的现金56,544,399.2236,263,729.8820,217,263.2471,002,895.38
  支付的各项税费20,916,254.7917,467,126.9411,676,199.737,737,768.67
  支付其他与经营活动有关的现金46,645,612.0632,693,904.1117,440,291.1891,508,294.03
  经营活动现金流出小计166,060,388.49113,241,601.363,097,829.15220,475,938.17
  经营活动产生的现金流量净额-32,800,616.16-24,624,078.54-20,896,941.7367,089,457.08
二、投资活动产生的现金流量:
  取得投资收益收到的现金284,780.82284,780.82--
  处置固定资产、无形资产和其他长期资产收回的现金净额4,281,3014,281,30163,30188,000
  处置子公司及其他营业单位收到的现金净额10,300,00010,300,000-44,625,315.68
  收到的其他与投资活动有关的现金10,000,00010,000,000--
  投资活动现金流入小计24,866,081.8224,866,081.8263,30144,713,315.68
  购建固定资产、无形资产和其他长期资产支付的现金10,899,997.598,992,526.58,511,396.0267,171,199.32
  支付其他与投资活动有关的现金10,296,617.1610,296,617.16-20,000,000
  投资活动现金流出小计21,196,614.7519,289,143.668,511,396.0287,171,199.32
  投资活动产生的现金流量净额3,669,467.075,576,938.16-8,448,095.02-42,457,883.64
三、筹资活动产生的现金流量:
  取得借款收到的现金139,000,000139,000,00084,000,00065,300,000
  收到其他与筹资活动有关的现金---120,365.13
  筹资活动现金流入小计139,000,000139,000,00084,000,00065,420,365.13
  偿还债务支付的现金69,260,00069,260,0009,000,000187,822,417.05
  分配股利、利润或偿付利息支付的现金4,693,323.053,161,525.61,613,606.1328,421,718.09
  支付其他与筹资活动有关的现金---231,937.65
  筹资活动现金流出小计73,953,323.0572,421,525.610,613,606.13216,476,072.79
  筹资活动产生的现金流量净额65,046,676.9566,578,474.473,386,393.87-151,055,707.66
五、现金及现金等价物净增加额35,915,527.8647,531,334.0244,041,357.12-126,424,134.22
  加:期初现金及现金等价物余额127,185,199.57127,185,199.57137,185,199.57253,609,333.79
  期末现金及现金等价物余额163,100,727.43174,716,533.59181,226,556.69127,185,199.57
补充资料:
  净利润--22,209,858.75--229,731,806.47
  资产减值准备--2,958,036.01-97,535,670.57
  固定资产和投资性房地产折旧-22,485,015.12-61,501,481.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,485,015.12-61,501,481.03
  无形资产摊销-721,218.2-1,376,622.22
  长期待摊费用摊销-1,373,603-1,103,322.35
  处置固定资产、无形资产和其他长期资产的损失--4,360,502.56-992,596.01
  固定资产报废损失-274,485.32-654,840.48
  公允价值变动损失-117,267.99-12,478,791.23
  财务费用-1,944,850.97-6,273,431.92
  投资损失--150,313.1--1,120,000
  递延所得税--438,832.41-20,418,912.78
  其中:递延所得税资产减少--424,425.27-19,435,425.8
    递延所得税负债增加--14,407.14-983,486.98
  存货的减少-5,656,816.56-57,453,727.24
  经营性应收项目的减少-7,600,034.48-165,639,258.36
  经营性应付项目的增加--35,893,193.61--127,487,390.64
  现金的期末余额-174,716,533.59-127,185,199.57
  减:现金的期初余额-127,185,199.57-253,609,333.79
  现金及现金等价物的净增加额-47,531,334.02--126,424,134.22
公告日期2026-10-302026-08-292026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑